Medicare Enrolled

Dr. Candice Demattia, MD

Family Medicine · Tomball, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
425 HOLDERRIETH BLVD STE 114, Tomball, TX 77375
2814757599
In practice since 2006 (19 years)
NPI: 1669427670 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Demattia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Demattia? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Demattia

Dr. Candice Demattia is a family medicine in Tomball, TX, with 19 years in practice. Based on federal Medicare data, Dr. Demattia performed 82 Medicare services across 73 unique beneficiaries.

Between the years covered by Open Payments, Dr. Demattia received a total of $8,951 from 57 pharmaceutical and/or device companies across 340 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Demattia is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 82 Medicare services$ $8,951 industry payments

Medicare Practice Summary

Medicare Utilization ↗
82
Medicare services
Bottom 13% in TX for family medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
73
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)37$101$292
Annual depression screening17$19$43
Annual wellness visit, follow-up15$134$298
Advance care planning consultation, first 30 min13$80$188
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,951
Total received (2018-2024)
Avg $1,279/year across 7 years
Top 6% in TX for family medicine
57
Companies
340
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,938 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$573
2023
$1,322
2022
$1,796
2021
$2,050
2020
$829
2019
$928
2018
$1,452

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Merz North America, Inc.
$2,190
MERZ NORTH AMERICA, INC.
$859
AstraZeneca Pharmaceuticals LP
$660
Amgen Inc.
$525
AbbVie Inc.
$398
Amarin Pharma Inc.
$390
Galderma Laboratories, L.P.
$328
Novo Nordisk Inc
$302
Astellas Pharma US Inc
$236
Indivior Inc.
$227
PFIZER INC.
$219
Shire North American Group Inc
$195
Janssen Pharmaceuticals, Inc
$194
Orexo US, Inc.
$191
Abbott Laboratories
$176
Allergan, Inc.
$165
GlaxoSmithKline, LLC.
$140
Boehringer Ingelheim Pharmaceuticals, Inc.
$107
SANOFI-AVENTIS U.S. LLC
$99
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$84
Kaleo, Inc.
$83
Teva Pharmaceuticals USA, Inc.
$77
Allergan Inc.
$71
ABBVIE INC.
$67
Baxter Healthcare
$63
Lilly USA, LLC
$57
Endogastric Solutions, Inc
$51
Takeda Pharmaceuticals U.S.A., Inc.
$50
Sunovion Pharmaceuticals Inc.
$50
IBSA Pharma Inc.
$48
Alkermes, Inc.
$47
Merck Sharp & Dohme Corporation
$46
Radius Health, Inc.
$43
Novartis Pharmaceuticals Corporation
$35
Biohaven Pharmaceuticals, Inc.
$34
JAZZ PHARMACEUTICALS INC.
$34
Bayer HealthCare Pharmaceuticals Inc.
$34
UCB, Inc.
$32
Neos Therapeutics, LP
$27
MannKind Corporation
$24
Medtronic MiniMed, Inc.
$23
Endo Pharmaceuticals Inc.
$23
Edwards Lifesciences Corporation
$23
Corium, LLC
$21
Xeris Pharmaceuticals, Inc.
$20
Ultragenyx Pharmaceutical Inc.
$19
Sumitomo Pharma America, Inc.
$18
Dynavax Technologies Corporation
$18
Ironshore Pharmaceuticals Inc.
$17
Noven Therapeutics, LLC
$16
Currax Pharmaceuticals LLC
$16
Vertical Pharmaceuticals, LLC
$15
Adlon Therapeutics L.P.
$15
Shield Therapeutics Inc
$15
Otsuka America Pharmaceutical, Inc.
$13
IDORSIA PHARMACEUTICALS US INC
$13
Synergy Pharmaceuticals Inc
$12
Top 3 companies account for 41.4% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADHANSIA XR · AFREZZA · AIRSUPRA · AJOVY · ANORO · AUSTEDO · AVYCAZ · AZSTARYS · Adzenys XR-ODT · Aimovig · Axium Sheath Braided DRG · BEVESPI AEROSPHERE · BOTOX · BOTOX COSMETIC · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CONTRAVE · DALVANCE · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · EMGALITY · ENTRESTO · ESOPHYX · EVENITY · Evzio · FARXIGA · FASENRA · FREESTYLE LIBRE 3 · GEMTESA · GVOKE PFS · Heplisav-B · Hillrom - Cardiac Ambulatory Monitor · Hillrom - Carnation Ambulatory Monitor · INVOKANA · JANUVIA · Jornay PM 20mg capsules (Bottle of 100) · Kerendia · LO LOESTRIN FE · LONHALA MAGNAIR · LORZONE · LYRICA · Licart · MYDAYIS · Myrbetriq · NASCOBAL · NURTEC ODT · Otezla · Ozempic · PREVNAR 20 · PROCLAIM · Proclaim Family of SCS IPGs · Proclaim IPG · Prolia · QULIPTA · QUVIVIQ · RELISTOR · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA 100/33 · STIOLTO RESPIMAT · SUBLOCADE · SUNOSI · SYMBICORT · Secuado · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TRUMENBA · Tirosint · Tresiba · Trulance · Tymlos · UBRELVY · VIBERZI · VIVITROL · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Vimpat · Vivitrol 380 mg · XARELTO · XIFAXAN · Xeomin · Zubsolv · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for family medicine in TX.

Equivalent to $10,916 per 100 Medicare services performed
Looking for a family medicine in Tomball?
Compare family medicines in the Tomball area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
917
Per 100K population
19.3
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE TOMBALL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Demattia is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 6%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Demattia experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Demattia performed 37 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Demattia receive payments from pharmaceutical companies?
Yes. Dr. Demattia received a total of $8,951 from 57 companies across 340 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Demattia's costs compare to other family medicines in Tomball?
Dr. Demattia's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Demattia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →